Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that results from cohorts 1 and 2 of 28-day multiple ascending dose (MAD) study of its oral small molecule GLP-1 receptor (GLP-1R) agonist ASC30 ...

Trump, rescheduling, and the future of cannabis: chaos, risk, and opportunity as operators navigate federal change, markets, ...

Phase II data set up late-stage trials, giving medical writers obesity drug combo keywords and full poster download.

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that results from cohorts 1 and 2 of 28-day multiple ascending dose (MAD) study of its oral small molecule GLP-1 receptor (GLP-1R) agonist ASC30 ...

A CBD seltzer or THC mocktail may seem like a good alternative to alcohol but their effects are very different.

A two-day meeting of the CDC's Advisory Committee on Immunization Practices, with new members appointed by RFK Jr., could ...

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe ...

In July and August, the US Food and Drug Administration approved drugs for lung cancer, multiple myeloma, and glioma.

Today, the World Anti-Doping Agency (WADA) publishes the 2026 List of Prohibited Substances and Methods (List), which was ...

Ladies and gentlemen, greetings, and welcome to MBX Biosciences Conference Call. Today's call is being recorded. [Operator Instructions] As a reminder, this conference is being recorded. It is now my ...